124 related articles for article (PubMed ID: 8806095)
21. Expression of the Ets-1 proto-oncogene in human gastric carcinoma: correlation with tumor invasion.
Nakayama T; Ito M; Ohtsuru A; Naito S; Nakashima M; Fagin JA; Yamashita S; Sekine I
Am J Pathol; 1996 Dec; 149(6):1931-9. PubMed ID: 8952528
[TBL] [Abstract][Full Text] [Related]
22. Meta-iodobenzylguanidine induces growth inhibition and apoptosis of neuroendocrine gastrointestinal tumor cells.
Höpfner M; Sutter AP; Beck NI; Barthel B; Maaser K; Jockers-Scherübl MC; Zeitz M; Scherübl H
Int J Cancer; 2002 Sep; 101(3):210-6. PubMed ID: 12209970
[TBL] [Abstract][Full Text] [Related]
23. BRAF
Dizdar L; Werner TA; Drusenheimer JC; Möhlendick B; Raba K; Boeck I; Anlauf M; Schott M; Göring W; Esposito I; Stoecklein NH; Knoefel WT; Krieg A
Int J Cancer; 2019 Mar; 144(6):1379-1390. PubMed ID: 30144031
[TBL] [Abstract][Full Text] [Related]
24. Co-amplification of c-myc and c-erbB-2 oncogenes in a poorly differentiated human gastric cancer.
Tsuchiya T; Ueyama Y; Tamaoki N; Yamaguchi S; Shibuya M
Jpn J Cancer Res; 1989 Oct; 80(10):920-3. PubMed ID: 2575609
[TBL] [Abstract][Full Text] [Related]
25. Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells.
Zhao Y; You H; Liu F; An H; Shi Y; Yu Q; Fan D
Cancer Lett; 2002 Nov; 185(2):211-8. PubMed ID: 12169395
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of manganese superoxide dismutase mRNA may correlate with aggressiveness in gastric and colorectal adenocarcinomas.
Toh Y; Kuninaka S; Oshiro T; Ikeda Y; Nakashima H; Baba H; Kohnoe S; Okamura T; Mori M; Sugimachi K
Int J Oncol; 2000 Jul; 17(1):107-12. PubMed ID: 10853026
[TBL] [Abstract][Full Text] [Related]
27. Role of methylation of the hMLH1 gene promoter in the development of gastric and colorectal carcinoma in the elderly.
Arai T; Kasahara I; Sawabe M; Honma N; Aida J; Tabubo K
Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S207-12. PubMed ID: 20590835
[TBL] [Abstract][Full Text] [Related]
28. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
29. No mutations of the Bub1 gene in human gastric carcinomas.
Shigeishi H; Yokozaki H; Kuniyasu H; Nakagawa H; Ishikawa T; Tahara E; Yasui W
Oncol Rep; 2001; 8(4):791-4. PubMed ID: 11410785
[TBL] [Abstract][Full Text] [Related]
30. p62 Expression in primary carcinomas of the digestive system.
Qian HL; Peng XX; Chen SH; Ye HM; Qiu JH
World J Gastroenterol; 2005 Mar; 11(12):1788-92. PubMed ID: 15793865
[TBL] [Abstract][Full Text] [Related]
31. Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression.
Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Lönnroth C; Lundholm K
Acta Oncol; 2007; 46(8):1107-12. PubMed ID: 17943472
[TBL] [Abstract][Full Text] [Related]
32. FGFR2 amplification is predictive of sensitivity to regorafenib in gastric and colorectal cancers in vitro.
Cha Y; Kim HP; Lim Y; Han SW; Song SH; Kim TY
Mol Oncol; 2018 Jun; 12(7):993-1003. PubMed ID: 29573334
[TBL] [Abstract][Full Text] [Related]
33. Isolation of a novel gene showing reduced expression in metastatic colorectal carcinoma cell lines and carcinomas.
Fukuda S; Kuroki T; Kohsaki H; Hayashi S; Ozaki K; Yamori T; Tsuruo T; Nakamori S; Imaoka S; Nakamura Y
Jpn J Cancer Res; 1997 Aug; 88(8):725-31. PubMed ID: 9330603
[TBL] [Abstract][Full Text] [Related]
34. Detection of circulating tumor cells in colorectal and gastric cancer using a multiplex PCR assay.
Vaiopoulos AG; Kostakis ID; Gkioka E; Athanasoula KCh; Pikoulis E; Papalambros A; Christopoulos P; Gogas H; Kouraklis G; Koutsilieris M
Anticancer Res; 2014 Jun; 34(6):3083-92. PubMed ID: 24922677
[TBL] [Abstract][Full Text] [Related]
35. MeCP2 and promoter methylation cooperatively regulate E-cadherin gene expression in colorectal carcinoma.
Darwanto A; Kitazawa R; Maeda S; Kitazawa S
Cancer Sci; 2003 May; 94(5):442-7. PubMed ID: 12824891
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA‑181a promotes cell proliferation and inhibits apoptosis in gastric cancer by targeting RASSF1A.
Yu J; Qi J; Sun X; Wang W; Wei G; Wu Y; Gao Q; Zheng J
Oncol Rep; 2018 Oct; 40(4):1959-1970. PubMed ID: 30106448
[TBL] [Abstract][Full Text] [Related]
37. Expression of tumor rejection antigens in colorectal carcinomas.
Sasatomi T; Suefuji Y; Matsunaga K; Yamana H; Miyagi Y; Araki Y; Ogata Y; Itoh K; Shirouzu K
Cancer; 2002 Mar; 94(6):1636-41. PubMed ID: 11920522
[TBL] [Abstract][Full Text] [Related]
38. Decreased expression of DCC mRNA in gastric and colorectal cancer.
Kataoka M; Okabayashi T; Orita K
Surg Today; 1995; 25(12):1001-7. PubMed ID: 8645930
[TBL] [Abstract][Full Text] [Related]
39. Expression in human lung cancer cell lines of genes of prohormone processing and the neuroendocrine phenotype.
Vos MD; Scott FM; Iwai N; Treston AM
J Cell Biochem Suppl; 1996; 24():257-68. PubMed ID: 8806108
[TBL] [Abstract][Full Text] [Related]
40. Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumor.
Takizawa N; Ohishi Y; Hirahashi M; Takahashi S; Nakamura K; Tanaka M; Oki E; Takayanagi R; Oda Y
Hum Pathol; 2015 Dec; 46(12):1890-900. PubMed ID: 26434631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
